HR17: Combining Drug Addiction Treatment and Perinatal HIV Prevention Leads to Good Outcomes

An integrated program offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.


PAS 2017: Many Doctors Wary of Providing PrEP for Young Patients

Only about a third of family practice and pediatric providers said they would be likely to prescribe HIV pre-exposure prophylaxis (PrEP) to adolescent patients, underlining the need to educate providers outside the HIV and sexually transmitted disease fields, according to a report at the 2017 Pediatric Academic Societies Meeting last week in San Francisco.


HIV PrEP Is Approved in Scotland

The Scottish Medicines Consortium (SMC) announced this week that it had accepted tenofovir disoproxil fumarate/emtricitabine (Truvada) for use within the Scottish National Health Service as pre-exposure prophylaxis (PrEP) to prevent HIV infection.


Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections coverage of the 2017 Conference on Retroviruses and Opportunistic infections (CROI 2017), February 13-16, 2017, in Seattle. coverage by topic

CROI website



BHIVA 2017: Large Fall in London HIV Diagnoses Is Due to Combination Prevention, Not Just PrEP

The number of new HIV diagnoses among gay men attending 5 key London clinics fell substantially during 2015 and 2016, Valerie Delpech of Public Health England reported at the British HIV Association (BHIVA) conference last week in Liverpool.


Obituary: Pioneering HIV Researcher Mark Wainberg

Mark Wainberg, a highly regarded clinician and researcher who helped advance HIV therapy and advocated for access to treatment and care worldwide, died on April 11 in a swimming accident in Florida at age 71.


CROI 2017: Accelerated Linkage to HIV Care Improves Retention by a Third

Close to 60% of adults benefitting from point-of-care CD4 cell count testing at HIV testing sites, accelerated antiretroviral therapy (ART) initiation, and SMS appointment reminders were retained in care after 1 year, compared to just 44% of those receiving the standard of care in Mozambique, according to findings from the Engage4Health study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle.